As more people receive genetic testing after a cancer diagnosis, newer variants have been identified that increase risk of developing cancer. A new study led by the University of Michigan Rogel Cancer Center finds that patients with three of these variants face no extra risk of dying from their cancer.

A new study in JAMA Pediatrics found that the spike in gun death rates during the first two years of the pandemic disproportionately affected adolescents ages 10-16, as well as adults over 30 years old. These increases lowered the peak risk of being a victim of a fatal shooting from 21 years old to 19 years old. The study also found that as adult gun death rates returned to pre-COVID levels in 2022 and 2023, gun homicide rates continued increasing for the 10-16 adolescent age group, doubling pre-pandemic rates.